Prognostic Imaging Research Laboratory (PIRL), Pre-clinical Imaging Section, Department of Radiology , UT Southwestern Medical Center , Dallas , Texas 75390-9058 , United States.
ACS Sens. 2019 May 24;4(5):1391-1398. doi: 10.1021/acssensors.9b00360. Epub 2019 Apr 30.
Oxygenation and tissue hypoxia play critical roles in mammalian biology and contribute to aggressive phenotypes in cancerous tumors, driving research to develop accurate and easy-to-implement methods for monitoring hypoxia in living cells and animal models. This study reports the chemiluminescent probe HyCL-4-AM, which contains a nitroaromatic sensing moiety and, importantly, an acetoxymethyl (AM) ester that dramatically improves operation in cells and animals. HyCL-4-AM provides a selective 60 000-fold increase in luminescence emission in the presence of rat liver microsomes (RLM). For cellular operation, the chemiluminescence response kinetics is sharply dependent on oxygen levels, enabling highly significant and reproducible measurement of hypoxia in living cells. Whole animal imaging experiments in muscle tissue and tumor xenografts show that HyCL-4-AM can differentiate between well oxygenated muscle tissue and hypoxic tumors, demonstrating potential for monitoring tumor reoxygenation via hyperoxic treatment.
氧合和组织缺氧在哺乳动物生物学中起着关键作用,并有助于癌症肿瘤的侵袭表型,促使人们研究开发用于监测活细胞和动物模型中缺氧的准确且易于实施的方法。本研究报告了化学发光探针 HyCL-4-AM,它包含一个硝基芳族传感部分,重要的是,它还含有一个乙酰氧甲基 (AM) 酯,这极大地改善了细胞和动物中的操作。HyCL-4-AM 在存在大鼠肝微粒体 (RLM) 时提供了发光发射的选择性 60,000 倍增加。对于细胞操作,化学发光响应动力学强烈依赖于氧水平,从而能够对活细胞中的缺氧进行高度显著和可重复的测量。在肌肉组织和肿瘤异种移植中的动物整体成像实验表明,HyCL-4-AM 可以区分氧合良好的肌肉组织和缺氧肿瘤,这表明通过高氧处理监测肿瘤再氧合的潜力。